Compound sixty has an extremely superior affinity to MDM2 (Ki < one nM), strong cellular action, and a very good oral pharmacokinetic profile. Compound 60 is able to achieving comprehensive and extended-Long lasting tumor regression in vivo and is at the moment in stage I medical trials for most cancers https://billl776kcu7.hyperionwiki.com/user